Lataa...

PCSK9抑制剂对不同基线水平的甘油三酯降低效果不同

OBJECTIVE: To investigate the triglyceride (TG)-lowering effects of PCSK9 inhibitor in patients with in different baseline triglyceride levels. METHODS: Between February, 2019 and March, 2020, a total of 59 patients were treated with PCSK9 inhibitor (Evolocumab) in 5 hospitals, including Nanfang Hos...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nan Fang Yi Ke Da Xue Xue Bao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 南方医科大学学报编辑部 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429163/
https://ncbi.nlm.nih.gov/pubmed/32895189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12122/j.issn.1673-4254.2020.08.11
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!